MeSH term
Frequency | Condition_Probility | Animals | 5 | 0.0 |
Humans | 20 | 0.0 |
Adult | 5 | 0.0 |
Alleles | 6 | 0.0 |
Apolipoproteins/*genetics | 7 | 10.0 |
Body Mass Index | 3 | 0.0 |
Comparative Study | 5 | 0.0 |
Gene Frequency | 6 | 0.0 |
Genotype | 4 | 0.0 |
Male | 14 | 0.0 |
Middle Aged | 5 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Postprandial Period | 2 | 2.0 |
Research Support, Non-U.S. Gov't | 14 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 9 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 11 | 0.0 |
Triglycerides/*blood/genetics | 3 | 60.0 |
Base Sequence | 4 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Female | 13 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Mice | 4 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Transfection | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Child | 3 | 0.0 |
Apolipoproteins C/*genetics | 4 | 4.0 |
Asian Continental Ancestry Group/genetics | 2 | 0.0 |
China | 2 | 0.0 |
Haplotypes/genetics | 3 | 0.0 |
Linkage Disequilibrium/genetics | 2 | 1.0 |
Mice, Knockout | 2 | 0.0 |
Triglycerides/*blood | 8 | 2.0 |
Chromosomes, Human, Pair 11/*genetics | 2 | 0.0 |
Apolipoprotein A-I/*genetics | 2 | 6.0 |
Apolipoproteins A/*genetics | 6 | 13.0 |
Genetic Predisposition to Disease | 4 | 0.0 |
Hyperlipidemia, Familial Combined/blood/epidemiology/*genetics | 2 | 66.0 |
Linkage Disequilibrium | 5 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Variation (Genetics) | 3 | 0.0 |
Multigene Family | 2 | 0.0 |
Cholesterol/blood | 2 | 0.0 |
Ethnic Groups/genetics | 2 | 1.0 |
Haplotypes | 4 | 0.0 |
Analysis of Variance | 2 | 0.0 |
*Apolipoproteins | 5 | 15.0 |
Hypertriglyceridemia/genetics | 2 | 13.0 |
